JMSB
John Marshall Bancorp, Inc.
JMSB has a slight edge over MS overall, supported by stronger valuation and stronger fundamentals.
MS
Morgan Stanley
MS has slightly lower modeled downside risk, despite its lower overall score.
JMSB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JMSB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JMSB.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
JMSB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.9x | $18.46 | -20% |
| Forward | 11x | $23.07 | — |
| Current | 12x | $23.07 | — |
| Fair | 13x | $24.76 | +7.3% |
| Expensive | 15x | $27.86 | +21% |
Historical ranges are pointers, not guarantees.
JMSB has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
JMSB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for JMSB, but weaker profitability.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over JMSB on the outlook, with more favorable profitability expectations.
JMSB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.09 | +12% |
| Q3 2026 | $1.87 | +33% |
| Q2 2026 | $1.72 | +29% |
| Q1 2026 | $1.58 | +27% |
| Q4 2025 | $1.49 | +24% |
| Q3 2025 | $1.41 | +18% |
JMSB earned $1.87 per share over the past year, up 33% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over JMSB on earnings, with stronger typical year-over-year growth.
JMSB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.1M | +11% |
| Q2 2026 | $18.8M | +22% |
| Q1 2026 | $16.8M | +15% |
| Q4 2025 | $16.4M | +14% |
| Q3 2025 | $16.3M | +18% |
| Q2 2025 | $15.4M | +22% |
| Q1 2025 | $14.6M | +16% |
| Q4 2024 | $14.3M | +13% |
JMSB's revenue has grown year over year for nine quarters in a row: $18M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 54% | +12 points |
| Q2 2026 | 48% | +5.4 points |
| Q1 2026 | 47% | +4.4 points |
| Q4 2025 | 47% | +4.9 points |
| Q3 2025 | 42% | +3.4 points |
| Q2 2025 | 43% | +2.9 points |
| Q1 2025 | 42% | -0.8 points |
| Q4 2024 | 43% | -3.9 points |
JMSB has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over JMSB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
JMSB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.4M | +522% |
| Q2 2026 | $5M | -32% |
| Q1 2026 | $8.5M | +29% |
| Q4 2025 | $6.9M | +31% |
| Q3 2025 | $1.2M | -9.6% |
| Q2 2025 | $7.4M | -27% |
| Q1 2025 | $6.6M | +6517% |
| Q4 2024 | $5.2M | -1.1% |
JMSB has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
JMSB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +248 shares |
| 1 year | -0.9% | -128K shares |
| 3 years | -0.7% | -98.7K shares |
JMSB has 14M diluted shares, down 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $2M |
| Q4 2025 | $768,000 |
| Q3 2025 | $294,000 |
| Q2 2025 | $1.3M |
| Q1 2025 | $46,000 |
| Q4 2024 | — |
JMSB spent $3M buying back its own shares over the past year, up 70% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over JMSB on shareholder dilution, with a more favorable share count trend.
JMSB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.2x | Net Cash |
| Q2 2026 | -2.4x | Net Cash |
| Q1 2026 | -2.3x | Net Cash |
| Q4 2025 | -1.8x | Net Cash |
| Q3 2025 | -3.2x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -3.8x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
JMSB has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
JMSB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.2 | Neutral |
| Stochastic | 39.7 | Neutral |
JMSB's weekly RSI is 57 (neutral) and its Stochastic is 40 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
JMSB PE vs Financial Services Sector
| Metric | JMSB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 5.2% below |
| PE % | 32 | 63 | 31 pts below |
JMSB has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
JMSB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.1 | 0% below |
| 20 week MA | $22.9 | 0.6% above |
| 50 week MA | $21.5 | 7.3% above |
| 100 week MA | $20.0 | 15% above |
| 200 week MA | $20.0 | 16% above |
JMSB has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
JMSB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.5 | $14.2 | -14% |
| 2021 | $14.2 | $19.6 | +38% |
| 2022 | $19.6 | $29.1 | +49% |
| 2023 | $29.1 | $22.6 | -23% |
| 2024 | $22.6 | $20.1 | -11% |
| 2025 | $20.1 | $20.4 | +1.8% |
| 2026 YTD | $20.4 | $23.1 | +13% |
JMSB has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.